Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Bristol Myers Squibb Announces Phase 3 CheckMate-816 Trial Met its Primary Endpoint


Benzinga | Nov 8, 2021 07:03AM EST

Bristol Myers Squibb Announces Phase 3 CheckMate-816 Trial Met its Primary Endpoint






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC